Damiani et al. found that tumor cells can maximize the use of α-ketoglutaric acid (α-KG), a catabolite of glutamine, into the TCA cycle, which is converted to pyruvate by malase and finally to lactate by LDHA (15) (Figure 1). Here, LDHA is linked to neoplasm.